AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23000523 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect Water Exposure (IWE)
Number of subjects: 3
Study 23000523 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Sorption (WS)
Number of subjects: 3
Study 20089774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius CUL61 and Lactobacillus paracasei CUL08 and Bifidobacterium animalis subsp. lactis CUL34 and Bifidobacterium bifidum CUL20; 1 x 10(10) colony-forming units administered daily during the last month of pregnancy and to infants aged 0-6 months.
Number of subjects: 454
Study 20089774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 454
Study 20089774 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and placebo groups
Number of subjects: 454
Study 17697906 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS hydromorphone
Number of subjects: 138
Study 17697906 — intervention group
Group type: COMPARATOR
Intervention: ER oxycodone
Number of subjects: 138
Study 16254588 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (Zn) supplementation for 6 months
Number of subjects: 433
Study 12188097 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX), 50 mg/day
Number of subjects: 15
Study 12188097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10553752 — intervention group
Group type: EXPERIMENTAL
Intervention: D-serine (30 mg/kg per day)
Number of subjects: 20
Study 10553752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8710463 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler sonography (PDS)
Number of subjects: 36
Study 8710463 — intervention group
Group type: COMPARATOR
Intervention: Conventional color Doppler sonography (CDS)
Number of subjects: 36
Study 1852401 — intervention group
Group type: EXPERIMENTAL
Intervention: High and low water content hydrogel lenses
Number of subjects: 6
Study 1852401 — intervention group
Group type: EXPERIMENTAL
Intervention: After lens removal
Number of subjects: 6
Study 6851723 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-dihydergot 2500 (2 X 2500 IU) with 0.5 mg dihydroergotamine (DHE)
Number of subjects: 500
Study 6851723 — intervention group
Group type: COMPARATOR
Intervention: Conventional low dose heparin regimen (2 X 5000 IU)
Number of subjects: 500
Study 30930187 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tRNS (n = 8)
Number of subjects: 19
Study 30930187 — intervention group
Group type: COMPARATOR
Intervention: Sham tRNS (n = 11)
Number of subjects: 19
Study 29194080 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic Intonation (HI) test
Number of subjects: 43
Study 29194080 — intervention group
Group type: EXPERIMENTAL
Intervention: Disharmonic Intonation (DI) test
Number of subjects: 43
Study 29194080 — intervention group
Group type: EXPERIMENTAL
Intervention: Italian Sentence Test with Adaptive Randomized Roving level (STARR) test
Number of subjects: 43
Study 29194080 — intervention group
Group type: COMPARATOR
Intervention: Bimodal listening
Number of subjects: 43
Study 29194080 — intervention group
Group type: COMPARATOR
Intervention: CI-only condition
Number of subjects: 43
Study 26569165 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea beverages with low catechin content (149.5 mg catechins with a galloyl moiety)
Number of subjects: 126
Study 26569165 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea beverages with high catechin content (246.5 mg catechins with a galloyl moiety)
Number of subjects: 126
Study 26569165 — intervention group
Group type: COMPARATOR
Intervention: Placebo (green tea beverages without catechins)
Number of subjects: 126
Study 25012418 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRI (escitalopram or citalopram) or dual therapy (serotonergic agent)
Number of subjects: 70
Study 25012418 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 70
Study 25012418 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined index of word fluency and RT
Number of subjects: 70
Study 22398243 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-mBN32 vaccine after first immunization
Number of subjects: 36
Study 22398243 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-mBN32 vaccine after second immunization
Number of subjects: 36
Study 22398243 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-mBN32 vaccine
Number of subjects: 36
Study 20104460 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (50 microg/kg bolus followed by 0.5 microg/kg/min infusion for 24 hours)
Number of subjects: 70
Study 20104460 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 70
Study 17568299 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (ACU)
Number of subjects: 47
Study 17568299 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT)
Number of subjects: 47
Study 17568299 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 47
Study 16248851 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenserine tartrate 10 mg
Number of subjects: 32
Study 16248851 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenserine tartrate 5 mg
Number of subjects: 32
Study 16248851 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenserine tartrate 20 mg
Number of subjects: 32
Study 12137863 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg daily on days 5‐9 after menses
Number of subjects: 19
Study 12137863 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate 50 mg daily on days 5‐9 after menses
Number of subjects: 19
Study 12137863 — intervention group
Group type: COMPARATOR
Intervention: Natural cycles (control)
Number of subjects: 19
Study 11770918 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial clock slides (Group C)
Number of subjects: 21
Study 11770918 — intervention group
Group type: COMPARATOR
Intervention: Traditional text slides (Group T)
Number of subjects: 21
Study 9594511 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) 10 cmH2O during nitrous oxide elimination
Number of subjects: 39
Study 9594511 — intervention group
Group type: COMPARATOR
Intervention: No positive end-expiratory pressure (PEEP) during nitrous oxide elimination
Number of subjects: 39
Study 7993190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of recombinant human erythropoietin (rhEPO) at a median dose of 33 U/kg body weight three times a week
Number of subjects: 90
Study 7993190 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration of recombinant human erythropoietin (rhEPO) at a median dose of 22 U/kg body weight
Number of subjects: 90
Study 7993190 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration of rhEPO
Number of subjects: 90
Study 7993190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of rhEPO
Number of subjects: 90
Study 2687357 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 15 micrograms/kg
Number of subjects: 9
Study 1212026 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of glucagon
Number of subjects: 20
Study 1212026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6783023 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (1200 mg daily for one week)
Number of subjects: 49
Study 6783023 — intervention group
Group type: COMPARATOR
Intervention: Control (multivitamins and fluid/electrolyte replacement, some received chlormethiazole or other tranquillisers)
Number of subjects: 49
Study 30188220 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BRJ; 12.9 mmol)
Number of subjects: 8
Study 30188220 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PL; 0.5 mmol)
Number of subjects: 8
Study 30007519 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated VR treatment (delivered in roughly six 30‐min sessions over a 2‐week period)
Number of subjects: 100
Study 30007519 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 100
Study 26518514 — intervention group
Group type: EXPERIMENTAL
Intervention: 1250 mg/day omega‐3 fatty acid + vitamin E placebo
Number of subjects: 120
Study 26518514 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU/day vitamin E + omega‐3 fatty acids placebo
Number of subjects: 120
Study 26518514 — intervention group
Group type: EXPERIMENTAL
Intervention: 1250 mg omega‐3 fatty acids/day + 400 IU/day vitamin E
Number of subjects: 120
Study 26518514 — intervention group
Group type: COMPARATOR
Intervention: omega‐3 fatty acids placebo + vitamin E placebo
Number of subjects: 120
Study 24999060 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term medication assisted treatment (LT-MAT) with buprenorphine/naloxone (BUP/NX)
Number of subjects: 1036
Study 24999060 — intervention group
Group type: COMPARATOR
Intervention: Short-term medication assisted treatment (ST-MAT) with buprenorphine/naloxone (BUP/NX)
Number of subjects: 1036
Study 24999060 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LT-MAT and ST-MAT with buprenorphine/naloxone (BUP/NX)
Number of subjects: 1036
Study 22836073 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 80 mg once weekly
Number of subjects: 20
Study 22836073 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg daily
Number of subjects: 20
Study 20598959 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided pes anserinus bursa injections
Number of subjects: 24
Study 20598959 — intervention group
Group type: COMPARATOR
Intervention: Unguided pes anserinus bursa injections
Number of subjects: 24
Study 17645718 — intervention group
Group type: EXPERIMENTAL
Intervention: T tube
Number of subjects: 107
Study 17645718 — intervention group
Group type: COMPARATOR
Intervention: No T tube
Number of subjects: 107
Study 16231339 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 158
Study 16231339 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal therapy
Number of subjects: 158
Study 12411528 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blocker (CCB), amlodipine, administered for 7 days prior to and for 7 days following the damage protocol
Number of subjects: 0
Study 12411528 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blocker (CCB), amlodipine
Number of subjects: 0
Study 12411528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10221356 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (15mg/70kg)
Number of subjects: 16
Study 10221356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 7860392 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdigitating chemotherapy and radiotherapy (COPE followed by thoracic radiation therapy)
Number of subjects: 61
Study 7860392 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemotherapy and radiotherapy (DDP and etoposide with concurrent thoracic radiation therapy)
Number of subjects: 61
Study 7860392 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) after completion of chemotherapy
Number of subjects: 61
Study 7860392 — intervention group
Group type: COMPARATOR
Intervention: Esophagitis
Number of subjects: 61
Study 7860392 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematologic and pulmonary toxicity
Number of subjects: 61
Study 1934001 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program (experimental group)
Number of subjects: 453
Study 1934001 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 453
Study 6127851 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenazepam + Sydnocarb
Number of subjects: 102
Study 6127851 — intervention group
Group type: COMPARATOR
Intervention: Phenazepam alone
Number of subjects: 102
Study 31903865 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid hormone treatment in euthyroid women with thyroid autoimmunity
Number of subjects: 0
Study 31903865 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioactive iodine (RAI) treatment
Number of subjects: 0
Study 31903865 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid hormone treatment for TSH >4 mIU/L
Number of subjects: 0
Study 30740877 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical phenytoin 2% powder spray
Number of subjects: 60
Study 30740877 — intervention group
Group type: COMPARATOR
Intervention: Regular sitz baths only
Number of subjects: 60
Study 30049503 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine ARER 100 mg
Number of subjects: 49
Study 30049503 — intervention group
Group type: COMPARATOR
Intervention: Extended-release morphine 100 mg
Number of subjects: 49
Study 30049503 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 49
Study 26864458 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographically measured epicardial fat thickness (EFT)
Number of subjects: 234
Study 26864458 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographically measured EFT
Number of subjects: 234
Study 25130704 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion
Number of subjects: 519
Study 25130704 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention
Number of subjects: 519
Study 21558456 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir-boosted ritonavir at therapeutic dose (1000/100 mg bid)
Number of subjects: 4
Study 21558456 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir-boosted ritonavir at supratherapeutic dose (1500/100 mg bid)
Number of subjects: 4
Study 21558456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 21558456 — intervention group
Group type: COMPARATOR
Intervention: Positive control (moxifloxacin 400 mg)
Number of subjects: 4
Study 21097481 — intervention group
Group type: EXPERIMENTAL
Intervention: RADPAD
Number of subjects: 22
Study 21097481 — intervention group
Group type: COMPARATOR
Intervention: No RADPAD
Number of subjects: 22
Study 17531335 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined schedule of external beam treatment (35.75 Gy in 13 fractions) followed by high dose rate brachytherapy (17 Gy in two fractions)
Number of subjects: 220
Study 17531335 — intervention group
Group type: COMPARATOR
Intervention: Standard radiotherapy (55 Gy in 20 fractions)
Number of subjects: 220
Study 16366808 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Relationship Therapy (BRT)
Number of subjects: 100
Study 16366808 — intervention group
Group type: COMPARATOR
Intervention: Standard Behavioral Couples Therapy (S-BCT)
Number of subjects: 100
Study 16366808 — intervention group
Group type: COMPARATOR
Intervention: Individual-Based Treatment (IBT)
Number of subjects: 100
Study 16366808 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational Attention Control Treatment (PACT)
Number of subjects: 100
Study 12459616 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 12
Study 10418023 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefepime (Group 1, n = 9)
Number of subjects: 18
Study 10418023 — intervention group
Group type: COMPARATOR
Intervention: Intermittent infusion of cefepime (Group 2, n = 9)
Number of subjects: 18
Study 7739307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous heparin infusion (partial thromboplastin time 1.5‐2 times baseline)
Number of subjects: 343
Study 7739307 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (adjusted dose with partial thromboplastin time 1.5‐2 times baseline)
Number of subjects: 343
Study 7739307 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 343
Study 2298592 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 or 400 ml ice water ingestion
Number of subjects: 89
Study 373836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 61
Study 373836 — intervention group
Group type: COMPARATOR
Intervention: Diatrizoate (Urografin 60%)
Number of subjects: 61
Study 29902234 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine cord application
Number of subjects: 36
Study 29902234 — intervention group
Group type: EXPERIMENTAL
Intervention: Health messages disseminated by ZamCAT field monitors
Number of subjects: 36
Study 26163337 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO supplementation during exercise (Ex-CHO)
Number of subjects: 32
Study 26163337 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo supplementation during exercise (Ex-PLA)
Number of subjects: 32
Study 26163337 — intervention group
Group type: COMPARATOR
Intervention: Resting control group (CON)
Number of subjects: 32
Study 24886235 — intervention group
Group type: EXPERIMENTAL
Intervention: STAIR Narrative Therapy
Number of subjects: 352
Study 24886235 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 352
Study 22246687 — intervention group
Group type: EXPERIMENTAL
Intervention: early locomotor training (early-LTP) initiated 2 months poststroke
Number of subjects: 408
Study 22246687 — intervention group
Group type: EXPERIMENTAL
Intervention: late locomotor training (late-LTP) initiated 6 months poststroke
Number of subjects: 408
Study 22246687 — intervention group
Group type: EXPERIMENTAL
Intervention: home exercise
Number of subjects: 408
Study 22246687 — intervention group
Group type: EXPERIMENTAL
Intervention: Berg Balance Scale score ≤ 42/56
Number of subjects: 408
Study 20616218 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution single nucleotide polymorphism mapping array analysis
Number of subjects: 372
Study 20616218 — intervention group
Group type: EXPERIMENTAL
Intervention: U133 Plus 2.0 expression array (Affymetrix)
Number of subjects: 372
Study 20616218 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization and expression quartile analysis
Number of subjects: 372
Study 18579575 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term antidepressant medication in patients with MDD
Number of subjects: 0
Study 18579575 — intervention group
Group type: COMPARATOR
Intervention: Acute administration of citalopram to controls
Number of subjects: 0
Study 18579575 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of abnormal signals in MDD
Number of subjects: 0
Study 16104964 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric device (PS)
Number of subjects: 69
Study 16104964 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotating drills (RD)
Number of subjects: 69
Study 12075396 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 41
Study 12075396 — intervention group
Group type: COMPARATOR
Intervention: Esmolol
Number of subjects: 41
Study 12075396 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 41
Study 9927101 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg pilocarpine tablets (20 mg/d)
Number of subjects: 373
Study 9927101 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5-mg pilocarpine tablets
Number of subjects: 373
Study 9927101 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 373
Study 7752293 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy coupled with urine monitoring
Number of subjects: 0
Study 2196772 — intervention group
Group type: EXPERIMENTAL
Intervention: DL‐diltiazem (0.4 mg/kg as a bolus intravenously, followed by an infusion of 15 mg/hr)
Number of subjects: 26
Study 2196772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 7002375 — intervention group
Group type: EXPERIMENTAL
Intervention: Myringotomy with adenoidectomy
Number of subjects: 42
Study 7002375 — intervention group
Group type: COMPARATOR
Intervention: Myringotomy without adenoidectomy
Number of subjects: 42
Study 31529059 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 μg Synacthen
Number of subjects: 42
Study 31529059 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg dexamethasone
Number of subjects: 42
Study 31529059 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 42
Study 31827470 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐15 pretreatment of NK effector cells
Number of subjects: 0
Study 31827470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27879993 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 534
Study 27879993 — intervention group
Group type: COMPARATOR
Intervention: Povidone-iodine
Number of subjects: 534
Study 25055766 — intervention group
Group type: EXPERIMENTAL
Intervention: Directly Observed Therapy (DOT)
Number of subjects: 43
Study 25055766 — intervention group
Group type: COMPARATOR
Intervention: Self-Administered Therapy (SAT)
Number of subjects: 43
Study 23768797 — intervention group
Group type: EXPERIMENTAL
Intervention: BodiMojo intervention for four weekly health class periods
Number of subjects: 178
Study 23768797 — intervention group
Group type: COMPARATOR
Intervention: Usual health curriculum
Number of subjects: 178
Study 21683991 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli HU2117
Number of subjects: 65
Study 21683991 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline (placebo)
Number of subjects: 65
Study 19333693 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cataract surgery
Number of subjects: 194
Study 19333693 — intervention group
Group type: COMPARATOR
Intervention: Separate bilateral cataract surgery
Number of subjects: 194
Study 16493559 — intervention group
Group type: EXPERIMENTAL
Intervention: Test CVC complete set
Number of subjects: 76
Study 16493559 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide wire ECG position control
Number of subjects: 76
Study 16493559 — intervention group
Group type: COMPARATOR
Intervention: Fluid column ECG position control
Number of subjects: 76
Study 16493559 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive fixation
Number of subjects: 76
Study 15315844 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified WHO regimen (Rifampicin 600 mg once a month supervised, 50 mg of Clofazimine and 100 mg of Dapsone daily unsupervised) and BCG 0.1 mg per dose 6 monthly
Number of subjects: 36
Study 15315844 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-drug treatment (MDT) and Mw (2 x 10(8) killed bacilli per dose) 6 monthly
Number of subjects: 36